CSS LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

CSS LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,000	Closed	-$340K	–	1088
2025 Q4	$340K	Buy	+2,000	New	+$307K	0.02%	653
2023 Q1	–	Sell	-5,952	Closed	-$948K	–	812
2022 Q4	$948K	Hold	5,952	–	–	0.05%	271
2022 Q3	$794K	Hold	5,952	–	–	0.04%	401
2022 Q2	$928K	Hold	5,952	–	–	0.04%	436
2022 Q1	$927K	Hold	5,952	–	–	0.03%	462
2021 Q4	$758K	Hold	5,952	–	–	0.03%	517
2021 Q3	$775K	Hold	5,952	–	–	0.03%	497
2021 Q2	$1.06M	Buy	+5,952	New	+$1.03M	0.04%	391

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CSS LLC's JAZZ Position: Q2 2026 in Review

CSS LLC opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 29,041 shares worth $7M. The stake represents 0.27% of the portfolio and ranks #66 among its holdings. This is a return to the name: CSS LLC previously reported a position in JAZZ as recently as Q2 2022.

CSS LLC first reported a position in JAZZ in Q2 2021 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

CSS LLC held 29,041 shares of Jazz Pharmaceuticals worth $7M as of Q2 2026.
Jazz Pharmaceuticals was a new CSS LLC position in Q2 2026.
Jazz Pharmaceuticals made up 0.27% of CSS LLC's portfolio in Q2 2026, its #66 holding.
CSS LLC first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.